|
|
Article: US Oncology Reports Third Quarter Operating Results.
- Article from:
- PR Newswire
- Article date:
- November 5, 2009
CopyrightCOPYRIGHT 2009 PR Newswire Association LLC. This material is published under license from the publisher through the Gale Group, Farmington Hills, Michigan. All inquiries regarding rights should be directed to the Gale Group. (Hide copyright information)
|
HOUSTON, Nov. 5 /PRNewswire/ -- US Oncology, Inc. ("US Oncology" or "the Company"), one of the nation's largest cancer care services companies, reported revenue of $901.5 million, Adjusted EBITDA of $62.1 million, EBITDA of $54.3 million, net loss of $0.9 million and operating cash flow of $62.5 million for the three months ended September 30, 2009.
Third Quarter Operating Results
-- Adjusted EBITDA for the third quarter of 2009 increased to $62.1
million from $54.8 million for the same period in 2008 due primarily
to growth in our network of physicians, increases in patient volumes
in medical oncology, radiation and diagnostics, ...